Stock Report: Mednax Inc. (MD)

Stock Report: Mednax Inc. (MD) - HE II MD boxes 7 19 13



We have done a deep dive on birth trends in the United States coming to the conclusion that the trend is turning positive after the worst decline in 40 years following the Great Recession.   In addition our medical consumption forecast models suggest a similar turn in medical utilization which continues to be impacted by post recessionary headwinds.  For MD, who’s doctors care for pre-term babies in their Pediatrix division, and those of MD’s American Anesthesiology division, birth trends and medical utilization  will be a key positive drivers going forward.



INTERMEDIATE TERM (TREND) (the next 3 months or more)

In the short term, utilization and births remain below potential, but have improved from the lows from 2009-2011.  In the first half of 2013, it appears the US Medical Economy hit a very soft patch in Q113, driving earnings misses at several companies related to MD.   While trends have improved sequentially, we have yet to see a major inflection point in growth.  While we are cautious on the slow pace of improvement to utilization and birth trends in the short term, our intermediate term analysis continues to point to recovery.   In addition, the short interest at MD remains elevated, but has been on the decline since Q412. Following the past 3 spikes in short interest, the most recent being the largest, MD shares tend to perform well as short interest declines.


LONG-TERM (TAIL) (the next 3 years or less)

MD has a highly defensible business model where growth is highly dependent on acquisition growth.  There are several structural changes taking place in the US Medical Economy which will continue to present an opportunity for MD to acquire growth for an extended period.  These structural changes favor large practices over sole practicioner offices.  Managed Care negotiations, medical liability insurance, and information technology, are all conspiring to raise the cost of operating a successful practice.  As a result MD continues to comment on a robust pipeline of acquisition candidates.  Consolidation in the US Medical Economy will reward those who have a successful strategy with stronger pricing power and operating efficiency, and punish those who don’t. 



Stock Report: Mednax Inc. (MD) - HE II MD chart 7 19 13

Cartoon of the Day: Bulls Leading the People

Investors rejoiced as centrist Emmanuel Macron edged out far-right Marine Le Pen in France's election day voting. European equities were up as much as 4.7% on the news.

read more

McCullough: ‘This Crazy Stat Drives Stock Market Bears Nuts’

If you’re short the stock market today, and your boss asks why is the Nasdaq at an all-time high, here’s the only honest answer: So far, Nasdaq company earnings are up 46% year-over-year.

read more

Who's Right? The Stock Market or the Bond Market?

"As I see it, bonds look like they have further to fall, while stocks look tenuous at these levels," writes Peter Atwater, founder of Financial Insyghts.

read more

Poll of the Day: If You Could Have Lunch with One Fed Chair...

What do you think? Cast your vote. Let us know.

read more

Are Millennials Actually Lazy, Narcissists? An Interview with Neil Howe (Part 2)

An interview with Neil Howe on why Boomers and Xers get it all wrong.

read more

6 Charts: The French Election, Nasdaq All-Time Highs & An Earnings Scorecard

We've been telling investors for some time that global growth is picking up, get long stocks.

read more

Another French Revolution?

"Don't be complacent," writes Hedgeye Managing Director Neil Howe. "Tectonic shifts are underway in France. Is there the prospect of the new Sixth Republic? C'est vraiment possible."

read more

Cartoon of the Day: The Trend is Your Friend

"All of the key trending macro data suggests the U.S. economy is accelerating," Hedgeye CEO Keith McCullough says.

read more

A Sneak Peek At Hedgeye's 2017 GDP Estimates

Here's an inside look at our GDP estimates versus Wall Street consensus.

read more

Cartoon of the Day: Green Thumb

So far, 64 of 498 companies in the S&P 500 have reported aggregate sales and earnings growth of 6.1% and 16.8% respectively.

read more

Europe's Battles Against Apple, Google, Innovation & Jobs

"“I am very concerned the E.U. maintains a battle against the American giants while doing everything possible to sustain so-called national champions," writes economist Daniel Lacalle. "Attacking innovation doesn’t create jobs.”

read more

An Open Letter to Pandora Management...

"Please stop leaking information to the press," writes Hedgeye Internet & Media analyst Hesham Shaaban. "You are getting in your own way, and blowing up your shareholders in the process."

read more